Don't Buy Ionis Pharmaceuticals Without Checking Its Fundamentals!

Shares of Healthcare sector company Ionis Pharmaceuticals moved -6.0% today, and are now trading at a price of $38.1. The mid-cap stock's daily volume was 1,114,801 compared to its average volume of 1,046,319. The S&P 500 index returned a 0.3% performance.

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company is based in Carlsbad and has 660 full time employees. Its market capitalization is $5,380,100,608.

19 analysts are following Ionis Pharmaceuticals and have set target prices ranging from $22 to $92 per share. On average, they have given the company a rating of hold. At today's prices, IONS is trading -23.97% away from its average analyst target price of $50.11 per share.

Date Reported Cash Flow from Operations ($ MM) Capital expenditures ($ MM) Free Cash Flow ($ MM) YoY Growth (%)
2021-12-31 31 -18 13 350.16
2020-12-31 36 -41 -5 -101.67
2019-12-31 346 -36 309 n/a
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.